↓ Skip to main content

Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3)

Overview of attention for article published in Neuropsychiatric Disease and Treatment, April 2019
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Readers on

mendeley
59 Mendeley